Table 5.
Pathological response after neo-adjuvant chemotherapy and definitive surgery.
| Study | pT0 (%) | <pT2 (%) |
|---|---|---|
| Kim et al. [12] | 12.5 | – |
| van de Putte et al. [13] | 31.4 | 43.2 |
| Galsky et al. [14] | 31 | – |
| Gandhi et al. [15] | 35–63 | – |
| Chau et al. [16] | 36.9 | – |
| Khaled et al. [17] | 25.6 | – |
| Fairey et al. [18] | 27.3 | 45.5 |
| Pal et al. [19] | 25 | 58 |
| Matsubara et al. [20] | 40 | 44 |
| Scosyrev et al. [21] | 20 | 44 |
| Kaneko et al. [22] | 50 | 63.6 |
| Dash et al. [7] | 26 | 36 |
| Herchenhorn et al. [23] | 26.7 | – |
–, not available; pT0, complete pathological response (pCR); <pT2, pathologic downstaging (pR).